5-Bromoquinoline hydrochloride, 95.0%, 5g

2-bromo-5,6-dichloro-1H-1,3-benzodiazole, 100mg

5-Bromo-4-methylthiophene-2-carboxylic acid, 95.0%, 25g

Benzyl 2-Naphthyl Ether>98.0%(GC)500g

2-Bromo-4-chloro-6-fluorophenol, 97.0%, 10g

2,6-Dibromobenzoic acid methyl ester, 95+%, 1g

2-[(5-Nitropyridin-2-yl)oxy]ethanol, 97.0%, 25g

5-ethyl-2-methylmorpholine, 95.0%, 500mg

(R,Z)-tert-Butyl (1-(7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate (Linagliptin Impurity), 98%, 50mg

2-Amino-6-methoxybenzaldehyde, 98+%, 1g

(R)-tert-Butyl 2-phenylpiperazine-1-carboxylate, 95.0%, 100mg

5-Chloro-3-(2-trimethylsilylethynyl)pyrazin-2-amine, 97%, 100mg

Infinity corrected plan PL 10x/0.25 IOS objective. Working distance 12.1 mm